Clinical research in cancer palliative care: a metaresearch analysis.


Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 23 10 2019
revised: 30 01 2020
accepted: 10 02 2020
pubmed: 27 3 2020
medline: 21 10 2020
entrez: 27 3 2020
Statut: ppublish

Résumé

This metaresearch of the clinicaltrials.gov database aims to evaluate how clinical research on palliative care is conducted within the setting of advanced cancer. Clinicaltrials.gov was searched to identify registered studies recruiting patients with cancer, and investigating issues relevant to palliative care. The European Organisation for Research and Treatment of Cancer QLQ-C15-PAL (Quality of Life in palliative cancer care patients) questionnaire was taken into account to define the research domains of interest. Studies investigating cancer-directed therapy, management of cancer treatment-related adverse events and diagnostic tests were excluded. Publication status was crosschecked using PubMed. Of 3950 identified studies, 514 were included. The most frequent reason for exclusion was cancer-directed therapy (2491). In 2007-2012, 161 studies were registered versus 245 in 2013-2018. Included studies were interventional (84%) or observational (16%). Most studies were monocentric (60%), sponsored by academia (79%), and conducted in North America (57%) or Europe (25%). Seventy-nine per cent of studies evaluated a heterogeneous population (>1 tumour type). Interventional studies most frequently investigated systemic drugs (34%), behavioural interventions (29%) and procedures for pain (24%). Pain, quality of life and physical function were the most frequently studied research domains (188, 95 and 52 studies, respectively). The most applied primary outcome measures were efficacy/symptom control (61%), quality of life (14%) and feasibility (12%). Only 16% of the closed studies had published results in PubMed. Our study describes the heterogeneous landscape of studies conducted to address the issues of patients with advanced cancer in palliative care. Albeit the observed increase in the number of studies over the last decade, the generalisation of the results brought by the existing trials is limited due to methodological issues and lack of reporting. A greater effort is needed to improve clinical research that supports evidence-based palliative cancer care.

Identifiants

pubmed: 32209567
pii: bmjspcare-2019-002086
doi: 10.1136/bmjspcare-2019-002086
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-258

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Marie Vinches (M)

Medical Department, EORTC Headquarters, Brussels, Belgium vinchesmarie@gmail.com.
Medical Oncology Department, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.

Anouk Neven (A)

Statistics Department, EORTC Headquarters, Brussels, Belgium.

Laurène Fenwarth (L)

Medical Department, EORTC Headquarters, Brussels, Belgium.

Mitsumi Terada (M)

International Trials Management Section, Clinical Research Support Office, National Cancer Center Hospital, Chuo-ku, Japan.

Giovanna Rossi (G)

Medical Department, EORTC Headquarters, Brussels, Belgium.

Sarah Kelly (S)

Fellowship Program, SIOP Europe, Brussels, Belgium.
Data Management Department, EORTC Headquarters, Brussels, Belgium.

Julien Peron (J)

Medical Oncology Department, Cancer Institute of the "Hospices Civils" of Lyon, Lyon, France.

Muriel Thomaso (M)

Supportive Care Department, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.

Mogens Grønvold (M)

Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen University Hospital, Kobenhavn, Denmark.

Teresa De Rojas (T)

Medical Department, EORTC Headquarters, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH